A Product and Pipeline Analysis of the U.S. Breast Cancer Therapeutics Market
A Product and Pipeline Analysis of the U.S. Breast Cancer Therapeutics Market
RELEASE DATE
25-Apr-2012
25-Apr-2012
REGION
North America
North America
Research Code: 9837-00-3E-00-00
SKU: HC00764-NA-MR_04396
$1,500.00
Special Price $1,125.00 save 25 %
In stock
SKU
HC00764-NA-MR_04396
Description
Although there are approximately 27 drugs on the market indicated for the treatment of breast cancer, there is still an unmet need to treat patients in this market. As a result, the breast cancer pharmaceutical pipeline remains strong. This research service presents a marketed and pipeline analysis of the breast cancer therapeutics market in the United States. It highlights the current market landscape and provides a competitive analysis of all marketed and pipeline drugs. Estimated patent expirations and launch timelines as well as late-stage clinical trial overviews are provided.
Table of Contents
Executive Summary
Introduction
Competitive Landscape
Hormonal Therapy
Targeted Therapy
Chemotherapy
Other Therapy
Certification
Legal Disclaimer
The Frost & Sullivan Story
Popular Topics
Although there are approximately 27 drugs on the market indicated for the treatment of breast cancer, there is still an unmet need to treat patients in this market. As a result, the breast cancer pharmaceutical pipeline remains strong. This research service presents a marketed and pipeline analysis of the breast cancer therapeutics market in the United States. It highlights the current market landscape and provides a competitive analysis of all marketed and pipeline drugs. Estimated patent expirations and launch timelines as well as late-stage clinical trial overviews are provided.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 9837-00-3E-00-00 |
Is Prebook | No |